Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ADF8 and ADF11 help root hairs grow by responding to hormones and environmental signals.

XEDAR deficiency prevents muscle degeneration in EDA-A2 transgenic mice.

Astrotactin2 affects hair follicle orientation and skin cell polarity.

PCOS women with COVID-19 have higher cardiometabolic risks.

Calcium is crucial for skin development and healing.

Steroids may not work well for alopecia areata because of high unoccupied receptors and low thioredoxin levels.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

No significant genetic link to alopecia areata was found in the Jordanian group.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Using SNP array testing helped quickly find the gene causing Woodhouse-Sakati syndrome in two related individuals.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.